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Patricia E Mascarelli1, Michael K Keel2,3, Michael Yabsley2,4, Lisa A Last2, Edward B Breitschwerdt1
and Ricardo G Maggi1*Abstract
Background: Hemotropic mycoplasmas are epicellular erythrocytic bacteria that can cause infectious anemia in
some mammalian species. Worldwide, hemotropic mycoplasmas are emerging or re-emerging zoonotic pathogens
potentially causing serious and significant health problems in wildlife. The objective of this study was to determine
the molecular prevalence of hemotropic Mycoplasma species in little brown bats (Myotis lucifugus) with and without
Pseudogymnoascus (Geomyces) destrucans, the causative agent of white nose syndrome (WNS) that causes significant
mortality events in bats.
Methods: In order to establish the prevalence of hemotropic Mycoplasma species in a population of 68 little brown
bats (Myotis lucifugus) with (n = 53) and without (n = 15) white-nose syndrome (WNS), PCR was performed targeting
the 16S rRNA gene.
Results: The overall prevalence of hemotropic Mycoplasmas in bats was 47%, with similar (p = 0.5725) prevalence
between bats with WNS (49%) and without WNS (40%). 16S rDNA sequence analysis (~1,200 bp) supports the
presence of a novel hemotropic Mycoplasma species with 91.75% sequence homology with Mycoplasma
haemomuris. No differences were found in gene sequences generated from WNS and non-WNS animals.
Conclusions: Gene sequences generated from WNS and non-WNS animals suggest that little brown bats could
serve as a natural reservoir for this potentially novel Mycoplasma species. Currently, there is minimal information
about the prevalence, host-specificity, or the route of transmission of hemotropic Mycoplasma spp. among bats.
Finally, the potential role of hemotropic Mycoplasma spp. as co-factors in the development of disease
manifestations in bats, including WNS in Myotis lucifugus, remains to be elucidated.
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Hemotropic mycoplasmas (hemoplasmas, formerly classi-
fied as Haemobartonella and Eperythrozoon spp.), are epi-
cellular erythrocytic bacterial parasites lacking a cell wall,
that can cause infectious anemia in some mammalian
species [1-5]. Worldwide, hemotropic Mycoplasmas are
emerging or re-emerging zoonotic pathogens that affect
livestock [6-14], wildlife [15-19], companion animals
[4,20-27], and humans [28-34]. These bacteria can cause
serious and economically significant health problems
in production animals. Infections with hemotropic* Correspondence: rgmaggi@ncsu.edu
1College of Veterinary Medicine, North Carolina State University, 1060 William
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unless otherwise stated.Mycoplasmas can range from asymptomatic to illnesses
characterized by overt life-threatening hemolytic anemia,
subtle chronic anemia, ill-thrift, and infertility. In addition,
these cell wall deficient bacteria may act as cofactors in the
progression of retroviral, neoplastic, and immune-mediated
diseases [1,34,35]. Unfortunately, little is known about
hemotropic Mycoplasma spp. prevalence, host-specificity,
or route of transmission in many wildlife species.
Historically, the diagnosis of hemotropic Mycoplasma
infections relied upon cytological examination of stained
blood smears. However, diagnostic sensitivity of blood
smear examination is generally less than 20%, and specifi-
city is hampered by artifacts, such as stain precipitates and
Howell-Jolly bodies [23,36,37]. The development of mo-
lecular assays, primarily targeting the 16S rRNA gene ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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novel animal hemotropic mycoplasmas [37-39], hence the
host range has increased in recent years.
The objective of this study was to determine the mo-
lecular prevalence of hemotropic Mycoplasma species in
a population of 68 little brown bats (Myotis lucifugus)
from Northeastern and Eastern US. In addition, all bats
were tested for Pseudogymnoascus (Geomyces) destruc-
tans, the causative agent of white nose syndrome (WNS)
and cause of significant mortality events in bats, to de-
termine if there was an association with Mycoplasma in-
fection status.
Methods
Sample collection
A total of 68 dead little brown bats were sampled pri-
marily during the mid-hibernation period from eastern
and northeastern US (Pennsylvania, Ohio, Kentucky,
West Virginia, Tennessee and North Carolina). Protocols
for capturing, handling and sample collection followed
the United States Fish and Wildlife Service Disinfection
Protocol for Bat Studies. Dead bats collected by hand
from roost substrates, were individually placed in plastic
bags and stored at −20°C until processing. Each bat was
submitted to the Southeastern Cooperative Wildlife
Disease Study at the College of Veterinary Medicine,
University of Georgia, Athens, Georgia, where gross exam-
ination was carried out on carcasses. To avoid DNA cross-
contamination, expendable supplies were used for each
animal. Bat samples were tested for P. destructans by
histological examination and molecular testing, either tar-
geting the internal transcribed spacer (ITS) region of the
rRNA gene complex [40,41] or the intergenic spacer (IGS)
region [42,43], as previously reported. Tissue samples
(spleen) collected from each individual were placed in 70%
ethanol and stored at −80°C until DNA extraction and
molecular analysis for evidence of hemotropic Myco-
plasma infections were performed.
Nucleic acid preparations
Total DNA from 25 mg of spleen tissue from each bat was
extracted according to manufacturers instructions using a
QIAamp DNA Mini Kita. After extraction, DNA concen-
tration and quality was measured using absorbance ratio
between 260/280 nmb. DNA was stored at −20°C until
testing.
PCR amplification
Amplification of hemotropic Mycoplasma 16S rDNA was
performed using two sets of oligonucleotides as previously
described [17]: HemMycop16S-41 s: 5’ GYA TGC MTA
AYA CAT GCA AGT CGA RCG 3’ and HemMyco16S-
938as: 5’ CTC CAC CAC TTG TTC AGG TCC CCG TC
3’ and HemMycop16S-322 s: 5’ GCC CATATT CCT ACGGGA AGC AGC AGT 3’ and HemMycop16S- 1420as: 5’
GTT TGA CGG GCG GTG TGT ACA AGA CC 3’. Se-
quences derived from amplicons obtained from each pri-
mer set (with an overlap of 600 bp) were aligned and edited
using AlignX (Vector NTI suite 11.5.1). Amplification was
performed in a 25-μl final volume reaction, the 25 μL reac-
tion mix contained 12.5 μL of Takara Ex Taq DNA Poly-
meraseW Premix (Fisher Scientific, Hampton, NH, USA),
0.2 μL of 100 μM of each forward and reverse primer,
7.3 μl of molecular grade water and 5 μl of template DNA.
Five microliters of RNAse free water was used as a PCR
negative control. Positive controls were prepared using 5 μl
of DNA from dog blood spiked with a 700 bp region of
M. hematoparvum 16S rRNA cloned in pGEM plasmid at
a final concentration of 2 copies per microliter. Amplifica-
tion was performed in an Eppendorf Mastercycler EPgra-
dientW (Hauppauge, NY, USA) as previously described [17].
PCR products were analyzed by 2% agarose gel electrophor-
esis and detected using ethidium bromide under ultraviolet
light. Amplicon products were sequenced by Eton Bio, Inc.
(RTP, NC, USA) to establish species strain identification
using chromatogram and alignment analysis (ContigEx-
pressW and AlignX software, Vector NTIW v10, Invitrogen,
Carlsbad, CA, USA).
Phylogenetic analysis
Each 16S rRNA sequence was compared to 26 other
hemotropic Mycoplasma sequences deposited in GenBank
database in order to compare phylogenetic relatedness
(evolutionary history) using the Neighbor-Joining method
(MEGA4W software). The tree is drawn to scale, with
branch lengths in the same units as those of the evolution-
ary distances used to infer the phylogenetic tree. The evo-
lutionary distances were computed using the Maximum
Composite Likelihood method and are in the units of the
number of base substitutions per site. MEGA4.
Results
Molecular and histological examination of little
brown bats
From a total of 68 bats, 53 (78%) had gross and histologic
lesions consistent with WNS and were all PCR positive for
P. destructans. The remaining 15 bats did not show any
signs of clinical abnormalities or fungal infection.
Hemotropic mycoplasma spp. DNA analysis
A total of 32 (47%) bats tested positive for hemotropic
Mycoplasma spp. using primers targeting a region covering
700 bp of the 16S rRNA gene. All 32 sequences were iden-
tical. Interestingly, a similar prevalence was found for
hemotropic Mycoplasma infection in bats with and without
WNS (26/53 (49%) and 6/15 (40%) respectively). Myco-
plasma amplification did not occur in 27 and 9 bats with
and without evidence of WNS, respectively. There was no
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prevalence of hemotropic Mycoplasmas in WNS vs non-
WNS affected bats.
A longer DNA sequence was obtained for 18 randomly
selected PCR positive samples (four of which were from
non-WNS animals), covering a 1,200 bp of the 16S rRNA
gene as previously described [19]. Again, all sequences
were identical. Sequence analysis using 1103/1200 bp,
identified the closest homology (91.9%) to a hemotropic
Mycoplasma detected in a human (Genbank GU562823),
and 1101/1200 (91.8%) with Mycoplasma haemomuris
(AB758440), suggesting the presence a novel hemotro-
pic Mycoplasma species in the sampled little brown bats
(Figure 1). There were no differences in the Mycoplasma
16S rDNA sequences derived from WNS-positive and
WNS-negative animals. The 16SrRNA sequence of the
hemotropic Mycoplasma species detected in bats was de-
posited in Genbank (accession number KF713538).Figure 1 Neighborhood-joining analysis using 25 taxa of hemotropic
Genbank database and the 16S rRNA gene sequence obtained from t
Candidatus status was omitted for simplicity. The evolutionary relationship wa
sum of branch length = 0.95954352 is shown. The tree is drawn to scale, with
used to infer the phylogenetic tree. The evolutionary distances were compute
of the number of base substitutions per site. All positions containing gaps and
option). Phylogenetic analyses were conducted in MEGA4.Discussion
Hemotropic Mycoplasma spp. appear to have co-evolved
with many animal species. The development of molecular
assays, primarily targeting the 16S rRNA gene of these mi-
crobes, has resulted in the recent recognition of several
novel animal and human hemoplasmas [15,17-19,44-47].
This study represents the first report of a novel, and as yet
incompletely characterized hemotropic Mycoplasma spe-
cies in little brown bats, with an overall prevalence of 47%.
There was no causative association with WNS, suggesting
that this bat species acts as a natural reservoir for this
uncharacterized Mycoplasma species. It is important to
note that the results presented here may be biased either
by the low number of bats assessed in either group or the
lack of appropriate control bats obtained from non-WNS
study sites. Therefore, conclusions on the role of hemotro-
pic Mycoplasma as a potential co-factor in the develop-
ment of WNS in bats cannot be derived from this study.Mycoplasma species (including Mycoplasma pneumonia) from the
he brown bats (Genbank accession KF713538) in this study.
s inferred using the Neighbor-Joining method. The optimal tree with the
branch lengths in the same units as those of the evolutionary distances
d using the Maximum Composite Likelihood method and are in the units
missing data were eliminated from the dataset (Complete deletion
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The relative high hemotropic Mycoplasmas DNA preva-
lence detected in WNS and non-WNS animals (49% and
40% respectively) together with the sequence analysis gen-
erated from the 16SrRNA gene suggest that the little
brown bats could serve as a natural reservoir for a novel
hemotropic Mycoplasma species. Hemotropic Myco-
plasma infection in mammals can cause a wide range of
clinical conditions, from sub-clinical to life-threatening
hemolytic anemia (particularly when immunosuppressed,
stressed from poor nutrition, pregnancy, or lactation, or
when concurrently infected with other more virulent path-
ogens, or more than one Mycoplasma species) [1,27,48].
Currently, there is no information about the prevalence,
host-specificity, or the route of transmission of hemotropic
Mycoplasma spp. in bats. The potential role of hemotropic
Mycoplasma as a cause of disease manifestations, and spe-
cifically WNS in Myotis lucifugus remains to be elucidated.
Endnotes
aQIAGEN Inc., Valencia, CA.
bNanodrop, Thermo Scientific, USA.
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